Have meds, will travel

This week’s Medical Monday is basically a boarding pass. Older adults are hopping on planes, crossing borders, and nudging very large institutions to move a little faster. They’re flying to Seoul for “well-aging” packages that bundle full-body scans with serious skin care, heading to Mexico for GLP-1 shots that don’t cost as much as a small car, watching Medicare finally stand up to blockbuster drug prices, and walking into ERs designed around their bodies instead of 20-somethings with sprained ankles. Add in Florida’s new longevity clinics and a scientific race to beat frailty itself, and you get the real theme: if the future of medicine arrives slowly, people 65+ are no longer waiting politely in the lobby.

✅ Today’s Feel-Good Checklist

The new Paris, at least for a certain kind of traveler, is Seoul. Not for croissants, not for romance, but for something far less poetic and far more practical: a full-body tune-up. A recent feature followed Americans, many in their 60s and 70s, who are flying to South Korea for multi-day “well-aging” programs — think medical checkup, beauty clinic, and concierge hotel stay rolled into one. Instead of one rushed appointment at home, they get a carefully choreographed few days that say: “We’re going to scan you, test you, and then make your skin glow while we’re at it.”

In certain Seoul districts, it feels like every second storefront is a clinic. There are regenerative dermatology centers offering laser resurfacing and injectable “skin boosters,” longevity clinics promising full-day heart, brain and cancer screening, hair-regrowth studios, and IV lounges with menus that read like vitamin cocktail lists. You don’t just book an appointment; you book an itinerary. Morning: fasting bloodwork and advanced imaging. Afternoon: dermatologist, consultation, treatments. Evening: nurse popping by the hotel to check on swelling and bandages.

For older Americans, the appeal is less “spa day” and more “health dashboard.” In one tightly packed visit, you can get advanced imaging, detailed blood panels, and skin or hair procedures that might take months to line up at home. Once you bundle everything, the total can come in 30–60% cheaper than similar care in big U.S. cities, even after airfare. Add a sense of being treated like a valued guest instead of a problem in the waiting room, and suddenly a long-haul flight feels less extravagant and more strategic.

This isn’t the old story of bargain dental work and cut-rate surgery. It’s a different kind of statement: if more advanced or more coordinated care is available elsewhere, older adults are willing to go find it. Seoul is essentially saying, “We take aging seriously,” and a growing number of Americans are replying, “Fine, then we’ll age with you.” And as you’ll see in Chapter 2, South Korea is only one stop on this new global health circuit.

Mark Spitznagel, who made $1B in a single day during the 2015 flash crash, warns markets are mimicking 1929. Yeah, just another oracle spouting gloom and doom, right?

Vanguard and Goldman Sachs forecast just 5% and 3% annual S&P returns respectively for the next decade (2024-2034).

Bonds? Not much better.

Enough warning signals—what’s something investors can actually do to diversify this week?

Almost no one knows this, but postwar and contemporary art appreciated 11.2% annually with near-zero correlation to equities from 1995–2024, according to Masterworks Data.

And sure… billionaires like Bezos and Gates can make headlines at auction, but what about the rest of us?

Masterworks makes it possible to invest in legendary artworks by Banksy, Basquiat, Picasso, and more – without spending millions.

23 exits. Net annualized returns like 17.6%, 17.8%, and 21.5%. $1.2 billion invested.

Shares in new offerings can sell quickly but…

👉 [My subscribers skip the waitlist].*

_{*Past performance is not indicative of future returns. Important Reg A disclosures: masterworks.com/cd.}

If Seoul is where older Americans go to fine-tune their collagen and collect futuristic scans, Mexico is where many of them go to fix a much more basic problem: the pharmacy bill. GLP-1 medications like Ozempic and Wegovy have become the headline stars of both diabetes care and weight-loss culture — and, in the U.S., the headline stars of sticker shock. With list prices often north of $1,000 a month, plenty of retirees have quietly discovered that it can be cheaper to book a flight than to refill at home.

Reporting has tracked Americans heading to border cities and resort towns to buy GLP-1s at Mexican pharmacies where prices can drop to a few hundred dollars a month. Some travelers make a weekend of it: one doctor visit, one prescription, a handful of boxes, and suddenly they’re set for several months. Do the math and, even with airfare and a couple of restaurant meals, they’re still paying less than U.S. retail. For retirees on fixed incomes, that arithmetic can turn a “someday” idea into a booked ticket.

Doctors and regulators are nervous about this trend for good reasons: authenticity of products, proper dosing, follow-up care, and potential side effects that need monitoring. There’s also the basic question of coordination — does your U.S. doctor know what you’re injecting? But from the patient’s point of view, the choice can feel brutally simple: pay a fortune, stop treatment altogether, or cross a border. Together, Seoul and Mexico show the same pattern: older adults are treating geography as part of their health plan and are willing to travel to feel better, live longer, or just get a fair price.

While some older adults are crossing borders to tame drug costs, Medicare is finally throwing its own punch at home. Thanks to the Inflation Reduction Act, the program has picked its first ten high-spend drugs for price negotiation. The new, lower “maximum fair prices” are scheduled to kick in for Medicare enrollees in 2026 — and although 2026 is still a couple months away, the fights, lawsuits, and lobbying have already started.

The chosen ten aren’t obscure. They include household names used to treat blood clots, heart failure, diabetes, and autoimmune disease — the kinds of medications that quietly run through millions of older adults’ pill organizers every week. These aren’t “nice-to-have” lifestyle drugs; they’re the ones that keep people out of the hospital and able to live independently. That’s exactly why they were targeted: huge Medicare spending, huge patient dependence.

Pharmaceutical companies argue that forced negotiation will discourage innovation and lead to fewer new treatments. They’ve filed lawsuits and launched public-relations campaigns warning of a drier drug pipeline. Advocates counter that it’s hard to talk about “innovation” with a straight face when many older adults are skipping doses or splitting pills to save money. Whatever you think of the politics, one thing is clear: for the first time, Medicare is acting less like a passive customer and more like the world’s toughest coupon clipper — and that’s very good news for people on the paying end of the pharmacy counter.

Regular emergency rooms are built for speed and chaos: bright lights, beeping monitors and staff sprinting past on their sixth cup of coffee. That’s great if you’ve just crashed a bicycle. It’s less great if you’re 78, a little unsteady on your feet, taking eight medications and not entirely sure why you feel so off. For older adults, the ER itself can become part of the problem — triggering confusion, falls and missed diagnoses.

Seniors rarely show up with one clean, simple issue. A fall might be related to a new blood-pressure pill, a urinary infection, dehydration or all three. Sitting for hours on a hard stretcher under fluorescent lights, with alarms going off every few seconds, is almost guaranteed to worsen confusion and agitation. When staff are rushed, the quiet, subtle clues that matter in older adults — a new tremor, a slightly slower response, a bit of slurred speech — can be easy to miss.

That’s why hospitals are carving out senior-friendly corners of the emergency department. These geriatric zones tend to have softer lighting, fewer alarms, recliner chairs instead of stretchers and staff trained in the “4Ms” of age-friendly care: What Matters (your goals), Medications (and their side effects), Mentation (thinking and mood) and Mobility (how safely you move). The focus isn’t just “Are your vitals okay?” but “Will you be safe at home once you leave?”

Hospitals piloting these spaces are seeing higher satisfaction from older patients and fewer quick return visits after discharge. When someone checks your walking, your thinking, your home situation and your medication list — not just your blood pressure — problems get caught earlier. It’s a small architectural change with a big emotional message: you’re not just an extra-complicated patient slowing down the line; you are exactly the kind of person the ER was built to serve.

Florida has always been where people go to retire. Increasingly, it’s where people go to practice not retiring from their health. Across the state, “longevity clinics” and high-end preventive centers are popping up with one promise: we can’t stop the calendar, but we might be able to slow down what it does to your body.

Traditional hospitals are built to rescue you once something has gone very wrong — a heart attack, a stroke, a bad infection. Longevity centers flip that script. They offer whole-body and brain scans to look for early trouble, detailed blood panels that go way beyond cholesterol, and risk assessments that blend genetics, lifestyle and aging markers. The sales pitch is simple: catch problems sooner and you give “future you” a much better shot.

Florida has three things longevity providers love: lots of older adults, big health systems willing to experiment and a culture already built around sunshine and movement. Some centers operate like boutique memberships — you pay a chunky fee and get a day or two of intense testing plus follow-up. Others are partnering with existing hospital systems or retirement communities to weave this kind of deep prevention into everyday care.

Right now, a lot of this is expensive and not fully covered by insurance. Not every test or supplement is backed by gold-standard evidence, and some of it leans heavily on aspirational “live forever” marketing. But underneath the hype is something likely to stick: more serious attention to midlife-and-beyond prevention, better screening and personalized plans that look at the whole person instead of one lab result at a time. Today, longevity clinics are a premium experiment. Tomorrow, their best ideas may quietly become standard care at the hospital down the street.

“Frailty” used to be a vague, discouraging label — code for someone older who is weaker, slower and more vulnerable, even if no one disease explains it. Now frailty itself is becoming a target. Researchers are asking a radical question: instead of simply accepting frailty as part of aging, can we measure it, treat it and even reverse pieces of it?

Doctors and scientists now use frailty scales that look at grip strength, walking speed, exhaustion and unintentional weight loss. That might sound clinical, but it’s actually hopeful: once you can assign a score, you can study what makes the number better or worse. Trials show that structured programs combining strength training and higher-protein diets can improve frailty scores and real-world performance — people walk farther, get out of chairs more easily and recover faster after illness.

Frailty is one of the best predictors of how someone will do after surgery, a fall or a serious infection. The stronger and more resilient you are going in, the better your odds of bouncing back. If science can make it easier for older adults to keep walking, carrying groceries and climbing stairs, that’s not vanity — that’s independence. The anti-frailty race isn’t about turning 80-year-olds into superheroes. It’s about stacking the deck so you can keep saying “yes” to the parts of life you actually care about.